Orient Pharma (OP), focusing on R&D and manufacturing and established on Feb 1, 2008, is the subsidiary of Orient Europharma(OEP). Located in Yunlin county in the central of Taiwan, the new pharmaceutical plant is a pharmaceutical plant of which manufacturing quality and compliance process meets extensive governmental regulations by PIC/S GMPand US FDA .
Orient Pharma not only develops its own drug forms and indications, but also obtains exclusive rights to manufacture patented products from international pharmaceutical companies, and applies for drug certifications in the United States, Japan, and Europe to enhance its presence in the global market.
Company Details
- Employees
- 21
- Founded
- -
- Address
- 5820 Oberlin Dr,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.oppharma.com
- HQ
- San Diego, California
Oep Innovations Inc Questions
Oep Innovations Inc's website is http://www.oppharma.com
Oep Innovations Inc's LinkedIn profile is https://www.linkedin.com/company/orient-pharma-innov
Oep Innovations Inc has
21 employees.
View email and phone details for 21
employees at Oep Innovations Inc.
Oep Innovations Inc's industry is
Pharmaceutical Manufacturing
Oep Innovations Inc's top competitors are
Oep Philippines,
友霖生技醫藥(股)公司 Orient Pharma Co., Ltd.,
Gsk,
Sun Pharmacy,
Formosa Biomedical Technology Corporation,
Syneurx International (Taiwan) Corp.,
Oep Group 友華集團,
Mithra Biotechnology,
Parexel,
Organon.
Oep Innovations Inc's categories are Pharmaceutical Manufacturing
Oep Innovations Inc's founding year is 2008
